By adjusting the sequencing of currently available treatments, improved compliance with therapy is ensured, and novel scientific and clinically relevant hypotheses can be further explored.
Mark S. Roh, MD, MMM
Advertisement
Articles by Mark S. Roh, MD, MMM
Advertisement
Latest Updated Articles
- It’s Tough to Make Predictions, Especially About the Future ... of Rectal Cancer
Published: June 15th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel T Cell Therapies Yield Decade-Long Remission in Epithelial Cancer
2
Mecbotamab Vedotin Shows Positive OS Results in Soft Tissue Sarcoma
3
Sacituzumab Govitecan Misses PFS End Point in Metastatic Breast Cancer
4
Imneskibart Yields Activity and Responses in Melanoma, NSCLC Cohorts
5
